Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,494
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Location: Los Angeles CA, Newport CA, San Antonio TX,
Sponsor: Nammi Therapeutics Inc
Sex: All
Age: 18+
Code: NCT06582017
Phase 1, Recruiting
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor
Location: LA CA, Santa Monica CA, Duarte CA, San Antonio TX,
Sponsor: ABL Bio, Inc.
Sex: All
Age: 18+
Code: NCT04762641
Phase 1, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: San Diego CA, Orange CA, Irvine CA, Murrieta CA,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
for
High Grade Glioma, MGMT-Unmethylated Glioblastoma,
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06504381
Phase 1, Phase 2, Recruiting
A Study of NX-1607 in Adults With Advanced Malignancies
for
Ovarian Cancer, Epithelial, Gastric Cancer,
Location: Los Angeles CA, San Francisco CA, Aurora CO, Seattle WA,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05107674
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma